Efficacy of traditional Chinese herbal therapy in vitro. A model system for atopic eczema: inhibition of CD23 expression on blood monocytes. 1995

Y Latchman, and G A Bungy, and D J Atherton, and M H Rustin, and J Brostoff
Department of Immunology, UCL Medical School, London, U.K.

Recently, there has been growing interest in the use of traditional Chinese herbal therapy (TCHT) decoctions for the treatment of atopic eczema (AE). The mode of action of this treatment is still unknown, and in order to investigate this we have analysed the effect of an extract of these herbs (TCHTE) on interleukin 4 (IL-4)-induced CD23 expression on peripheral blood monocytes from non-atopic subjects. We found that TCHTE inhibited CD23 expression up to 60% (P < 0.001), whereas the placebo extract had no significant effect on CD23 expression. This inhibition was dose-dependent, and TCHTE was effective at a concentration of 250 micrograms/ml (P = 0.001). If TCHTE or placebo was added after IL-4, the action of TCHTE could still be seen at 12 h. This inhibition was not due to cell death, as peripheral blood mononuclear cells (PBMCs) cultured with TCHTE or placebo at a concentration used in these experiments had a similar viability to control cultures. Down-regulation of the low affinity receptors for IgE on antigen-presenting cells in patients with AE may contribute to the benefit observed following treatment with TCHT.

UI MeSH Term Description Entries
D008297 Male Males
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003876 Dermatitis, Atopic A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. Eczema, Atopic,Eczema, Infantile,Neurodermatitis, Atopic,Neurodermatitis, Disseminated,Atopic Dermatitis,Atopic Eczema,Atopic Neurodermatitis,Disseminated Neurodermatitis,Infantile Eczema
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004365 Drugs, Chinese Herbal Chinese herbal or plant extracts which are used as drugs to treat diseases or promote general well-being. The concept does not include synthesized compounds manufactured in China. Chinese Herbal Drugs,Plant Extracts, Chinese,Chinese Drugs, Plant,Chinese Plant Extracts,Extracts, Chinese Plant,Herbal Drugs, Chinese
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Y Latchman, and G A Bungy, and D J Atherton, and M H Rustin, and J Brostoff
July 1994, International archives of allergy and immunology,
Y Latchman, and G A Bungy, and D J Atherton, and M H Rustin, and J Brostoff
March 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology,
Y Latchman, and G A Bungy, and D J Atherton, and M H Rustin, and J Brostoff
July 1992, Lancet (London, England),
Y Latchman, and G A Bungy, and D J Atherton, and M H Rustin, and J Brostoff
March 1996, International archives of allergy and immunology,
Y Latchman, and G A Bungy, and D J Atherton, and M H Rustin, and J Brostoff
September 2013, The Cochrane database of systematic reviews,
Y Latchman, and G A Bungy, and D J Atherton, and M H Rustin, and J Brostoff
April 2005, The Cochrane database of systematic reviews,
Y Latchman, and G A Bungy, and D J Atherton, and M H Rustin, and J Brostoff
October 2004, The Cochrane database of systematic reviews,
Y Latchman, and G A Bungy, and D J Atherton, and M H Rustin, and J Brostoff
September 2013, The Cochrane database of systematic reviews,
Y Latchman, and G A Bungy, and D J Atherton, and M H Rustin, and J Brostoff
January 2013, Forschende Komplementarmedizin (2006),
Y Latchman, and G A Bungy, and D J Atherton, and M H Rustin, and J Brostoff
November 1995, The British journal of dermatology,
Copied contents to your clipboard!